LB Pharmaceuticals Inc
LBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001691082
No open-market purchases or sales by LB Pharmaceuticals Inc insiders were filed in the last 90 days; 114 institutions reported holding it in 13F filings for Q2 2026, worth $1.00B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in LB Pharmaceuticals Inc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 53
- +53 vs. Q2 2025
- Shares held
- 19.9M
- +19.9M vs. Q2 2025
- Total value
- $314.9M
- +$314.9M vs. Q2 2025
- New holders
- 53
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 114 | $1.00B |
| Q1 2026 | 77 | $693.7M |
| Q4 2025 | 68 | $551.8M |
| Q3 2025 | 53 | $331.2M |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding LB Pharmaceuticals Inc; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 3,352,804 | $52.9M | 1.48% | +3,352,804 | New |
| Ra Capital Management, L.P. | 1,776,958 | $28.1M | 0.35% | +1,776,958 | New |
| TCG Crossover Management, LLC | 1,745,016 | $27.6M | 1.36% | +1,745,016 | New |
| Commodore Capital LP | 1,500,000 | $23.7M | 1.16% | +1,500,000 | New |
| Logos Global Management LP | 1,130,000 | $17.8M | 1.76% | +1,130,000 | New |
| JPMorgan Chase & Co | 1,032,603 | $16.3M | 0.00% | +1,032,603 | New |
| BlackRock, Inc. | 975,000 | $15.4M | 0.00% | +975,000 | New |
| Balyasny Asset Management LLC | 968,274 | $15.3M | 0.03% | +968,274 | New |
| Vivo Capital, LLC | 800,000 | $12.6M | 1.02% | +800,000 | New |
| Jennison Associates LLC | 739,040 | $11.7M | 0.01% | +739,040 | New |
| Alyeska Investment Group, L.P. | 675,000 | $10.7M | 0.03% | +675,000 | New |
| Nantahala Capital Management, LLC | 675,000 | $10.7M | 0.66% | +675,000 | New |
| Citadel Advisors LLC | 539,370 | $8.52M | 0.01% | +539,370 | New |
| Millennium Management LLC | 538,169 | $8.50M | 0.01% | +538,169 | New |
| Soleus Capital Management, L.P. | 400,000 | $6.32M | 0.34% | +400,000 | New |
| FMR LLC | 369,100 | $5.83M | 0.00% | +369,100 | New |
| Wellington Management Group LLP | 344,657 | $5.44M | 0.00% | +344,657 | New |
| Goldman Sachs Group Inc | 343,523 | $5.42M | 0.00% | +343,523 | New |
| Nan Fung Group Holdings Ltd | 300,000 | $4.74M | 7.95% | +300,000 | New |
| Price T Rowe Associates Inc | 282,644 | $4.46M | 0.00% | +282,644 | New |
| Marshall Wace, LLP | 255,526 | $4.03M | 0.00% | +255,526 | New |
| Adage Capital Partners GP, L.L.C. | 200,000 | $3.16M | 0.01% | +200,000 | New |
| Baker Bros. Advisors LP | 200,000 | $3.16M | 0.02% | +200,000 | New |
| Integral Health Asset Management, LLC | 100,000 | $1.58M | 0.12% | +100,000 | New |
| Ameriprise Financial Inc | 77,450 | $1.22M | 0.00% | +77,450 | New |
| Silverarc Capital Management, LLC | 70,000 | $1.11M | 0.16% | +70,000 | New |
| Boxer Capital Management, LLC | 70,000 | $1.11M | 0.35% | +70,000 | New |
| HRT Financial LP | 58,815 | $928.0K | 0.00% | +58,815 | New |
| Monashee Investment Management LLC | 40,000 | $631.6K | 0.31% | +40,000 | New |
| TD Asset Management Inc | 36,780 | $580.8K | 0.00% | +36,780 | New |
| Point72 (DIFC) Ltd | 34,003 | $536.9K | 0.04% | +34,003 | New |
| Barclays PLC | 30,839 | $486.9K | 0.00% | +30,839 | New |
| Jane Street Group, LLC | 30,345 | $479.1K | 0.00% | +30,345 | New |
| Acuta Capital Partners, LLC | 30,000 | $473.7K | 0.49% | +30,000 | New |
| Hudson Bay Capital Management LP | 27,097 | $427.9K | 0.00% | +27,097 | New |
| Squarepoint Ops LLC | 20,825 | $328.8K | 0.00% | +20,825 | New |
| Oxford Asset Management LLP | 17,763 | $280.5K | 0.09% | +17,763 | New |
| Manufacturers Life Insurance Company, The | 17,488 | $276.1K | 0.00% | +17,488 | New |
| Aristeia Capital LLC | 15,270 | $241.1K | 0.01% | +15,270 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 14,535 | $229.5K | 0.04% | +14,535 | New |
| Quantessence Capital LLC | 14,225 | $224.6K | 0.07% | +14,225 | New |
| Geode Capital Management, LLC | 13,591 | $214.6K | 0.00% | +13,591 | New |
| Two Sigma Investments, LP | 13,500 | $213.2K | 0.00% | +13,500 | New |
| Brevan Howard Capital Management LP | 13,259 | $209.4K | 0.00% | +13,259 | New |
| Jefferies Financial Group Inc. | 13,100 | $206.8K | 0.00% | +13,100 | New |
| XTX Topco Ltd | 11,276 | $178.0K | 0.01% | +11,276 | New |
| Landscape Capital Management, L.L.C. | 10,638 | $168.0K | 0.01% | +10,638 | New |
| Morgan Stanley | 9,605 | $151.7K | 0.00% | +9,605 | New |
| Federated Hermes, Inc. | 9,000 | $142.1K | 0.00% | +9,000 | New |
| Bank of America Corp | 1,700 | $26.8K | 0.00% | +1,700 | New |
| UBS Group AG | 1,055 | $16.7K | 0.00% | +1,055 | New |
| Wells Fargo & Company | 1,000 | $15.8K | 0.00% | +1,000 | New |
| Quarry LP | 11 | $174 | 0.00% | +11 | New |